Rejuvel Bio-Sciences, Inc.
- Jurisdiction
United States - ISIN
US7594081074 (NUUU )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
2
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
Rejuvel Bio-Sciences, Inc., a development stage company, produces, distributes, markets, and sells skin care products worldwide. Read full profile
Fundamentals
- Net revenue
€159.78K - Gross margin
47.4% - EBIT
-€1.07M - EBIT margin
-672.7% - Net income
-€897.33K - Net margin
-561.6%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions